Modeling Parkinson's Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells (Q60919555)

2

0 references

Jiro Fukae

3

0 references

Junichi Yuasa-Kawada

4

0 references

Yoshio Tsuboi

International Journal of Molecular Sciences

5

0 references

language of work or name

English

0 references

publication date

4 December 2018

4 references

25 April 2019

19 September 2019

12 October 2019

8 October 2022

4 references

25 April 2019

19 September 2019

12 October 2019

8 October 2022

19

0 references

issue

12

0 references

page(s)

3870

0 references

copyright license

Creative Commons Attribution

4 references

25 April 2019

19 September 2019

12 October 2019

8 October 2022

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Neurobiology. Better cells for brain repair

1 reference

12 December 2020

Parkinson's disease. Second of two parts

1 reference

12 December 2020

Using human neural stem cells to model neurological disease.

1 reference

12 December 2020

Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation

1 reference

12 December 2020

Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

1 reference

12 December 2020

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

1 reference

12 December 2020

Mixed brain pathologies account for most dementia cases in community-dwelling older persons

1 reference

12 December 2020

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

1 reference

12 December 2020

Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.

1 reference

12 December 2020

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

1 reference

12 December 2020

Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies

1 reference

12 December 2020

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

1 reference

12 December 2020

Disease-specific induced pluripotent stem cells

1 reference

12 December 2020

Induced pluripotent stem cells from a spinal muscular atrophy patient

1 reference

12 December 2020

DCTN1 mutations in Perry syndrome

1 reference

12 December 2020

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

1 reference

12 December 2020

Parkinson's disease: from monogenic forms to genetic susceptibility factors

1 reference

12 December 2020

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

1 reference

12 December 2020

Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy

1 reference

12 December 2020

Genetic animal models of Parkinson's disease

1 reference

12 December 2020

What can pluripotent stem cells teach us about neurodegenerative diseases?

1 reference

12 December 2020

TDP-43 pathology occurs infrequently in multiple system atrophy

1 reference

12 December 2020

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress

1 reference

12 December 2020

The use of induced pluripotent stem cells in drug development

1 reference

12 December 2020

Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells

1 reference

12 December 2020

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

1 reference

12 December 2020

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

1 reference

12 December 2020

Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells

1 reference

12 December 2020

Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells

1 reference

12 December 2020

Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease

1 reference

12 December 2020

Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.

1 reference

12 December 2020

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease

1 reference

12 December 2020

Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue

1 reference

12 December 2020

Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects

1 reference

12 December 2020

Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease

1 reference

12 December 2020

Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.

1 reference

12 December 2020

Biotechnology: Rewriting a genome

1 reference

12 December 2020

Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression

1 reference

12 December 2020

The presenilin-1 ΔE9 mutation results in reduced γ-secretase activity, but not total loss of PS1 function, in isogenic human stem cells

1 reference

12 December 2020

α-Synucleinopathy phenotypes

1 reference

12 December 2020

Human iPSC-based modeling of late-onset disease via progerin-induced aging

1 reference

12 December 2020

Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations

1 reference

12 December 2020

Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation

1 reference

12 December 2020

Development and applications of CRISPR-Cas9 for genome engineering

1 reference

12 December 2020

Parkinsonian syndrome in familial frontotemporal dementia

1 reference

12 December 2020

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

1 reference

12 December 2020

Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes.

1 reference

12 December 2020

Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia.

1 reference

12 December 2020

Methods of induced pluripotent stem cells for clinical application

1 reference

12 December 2020

Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors

1 reference

12 December 2020

1 reference

12 December 2020

Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture

1 reference

12 December 2020

Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency

1 reference

12 December 2020

I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway

1 reference

12 December 2020

Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU Protein

1 reference

12 December 2020

Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.

1 reference

12 December 2020

Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human Models

1 reference

12 December 2020

Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells

1 reference

12 December 2020

Cell-based therapies for Parkinson disease—past insights and future potential

1 reference

12 December 2020

Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells

1 reference

12 December 2020

Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence

1 reference

12 December 2020

Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes

1 reference

12 December 2020

Rationally engineered Cas9 nucleases with improved specificity

1 reference

12 December 2020

Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.

1 reference

12 December 2020

Cytoplasmic aggregates of dynactin in iPSC-derived tyrosine hydroxylase-positive neurons from a patient with Perry syndrome

1 reference

12 December 2020

Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons

1 reference

12 December 2020

A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells

1 reference

12 December 2020

Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons

1 reference

12 December 2020

Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1.

1 reference

12 December 2020

Induced pluripotent stem cell technology: a decade of progress

1 reference

12 December 2020

Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy

1 reference

12 December 2020

Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons

1 reference

12 December 2020

The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria

1 reference

12 December 2020

Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.

1 reference

12 December 2020

Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein.

1 reference

12 December 2020

Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson's disease.

1 reference

12 December 2020

Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges

1 reference

12 December 2020

Reduced TDP-43 Expression Improves Neuronal Activities in a Drosophila Model of Perry Syndrome

1 reference

12 December 2020

Creation of a library of induced pluripotent stem cells from Parkinsonian patients.

1 reference

12 December 2020

Neuropathology of Parkinson disease

1 reference

12 December 2020

Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy

1 reference

12 December 2020

Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.

1 reference

12 December 2020

Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease

1 reference

12 December 2020

A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci.

1 reference

12 December 2020

Establishing diagnostic criteria for Perry syndrome

1 reference

12 December 2020

The Potential of iPSCs for the Treatment of Premature Aging Disorders

1 reference

12 December 2020

Parkinson's disease: experimental models and reality

1 reference

12 December 2020

Behavioral defects in a DCTN1G71A transgenic mouse model of Perry syndrome

1 reference

12 December 2020

The rise of three-dimensional human brain cultures

1 reference

12 December 2020

Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay

1 reference

12 December 2020

Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes.

1 reference

12 December 2020

T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease

1 reference

12 December 2020

Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy

1 reference

12 December 2020